This paper highlights the importance of lipid-based colloidal carriers and their
pharmaceutical implications in the delivery of peptides and proteins for oral and parenteral …

Discovery of insulin in the early 1900s initiated the research and development to improve
the means of therapeutic protein delivery in patients. In the past decade, great emphasis has …

Bevacizumab is an anti-vascular endothelial growth factor drug that can be used to treat
choroidal neovascularization (CNV). Bevacizumab-loaded multivesicular liposomes (Bev …

Lamellar liposome technology has been used for several decades to produce sustained-
release drug formulations for parenteral administration. Multivesicular liposomes are …

Multivesicular liposomes (MVLs) are non-concentric, lipid-based micron-sized spherical
particles. The usage of MVL for sustained drug delivery has seen progression over the last …

Lipid based carriers have attracted increasing scientiˆc and commercial attention during the
last few years as an alternative material for the delivery of peptides and proteins concerned …

Breviscapine, a well-known bioactive flavonoid ingredient extracted from the traditional
Chinese medicine, has been extensively used in clinic to treat ischemic cerebrovascular and …

Drug development is a key point in the research of new therapeutic treatments for increasing
maximum drug loading and prolonged drug effect. Encapsulation of drugs into multivesicular …

The aim of the present study was to develop a novel dosage form of multivesicular
liposomes for oleanolic acid (OA) to overcome its poor solubility, prolong therapeutic drug …

The purpose of this work is to investigate the entrapment of protein molecules in cubosomic
nanocarriers that are sterically stabilized by an amphiphilic poly (ethylene glycol)(PEG) …